{
    "nctId": "NCT00122070",
    "title": "Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Provide written informed consent before beginning any study related activities"
                    },
                    {
                        "type": "variable",
                        "value": "Be between age 18 and 55 years"
                    },
                    {
                        "type": "variable",
                        "value": "Be able to speak, read and write English and follow simple instructions for completing self-rated scales"
                    },
                    {
                        "type": "variable",
                        "value": "Meet DSM-IV criteria for BPD as assessed by the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II)"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    },
                    {
                        "type": "variable",
                        "value": "Must have maximum age of 55 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Are pregnant or lactating"
                            },
                            {
                                "type": "variable",
                                "value": "Have participated in any other studies involving investigational products within 30 days prior to entry into this study"
                            },
                            {
                                "type": "variable",
                                "value": "Are undergoing an acute withdrawal syndrome from drugs or alcohol"
                            },
                            {
                                "type": "variable",
                                "value": "Have an Axis I diagnosis of Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder or Bipolar I Disorder as diagnosed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), and pertinent subsequent for ruling out exclusionary diagnoses"
                            },
                            {
                                "type": "variable",
                                "value": "Have an unstable medical disorder as determined by physical examination or laboratory testing. The primary investigator will be responsible for making this judgment based on the above"
                            },
                            {
                                "type": "variable",
                                "value": "Had an unsatisfactory response to a previous adequate trial of quetiapine as judged by a study investigator"
                            },
                            {
                                "type": "variable",
                                "value": "Patients cannot begin psychotherapy during the study period, but may continue if started prior to the study"
                            },
                            {
                                "type": "variable",
                                "value": "Patients who are currently receiving quetiapine therapy may not undergo a washout period and then restart quetiapine in the study"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Be able to speak, read and write English and follow simple instructions for completing self-rated scales'), Symbol('Be between age 18 and 55 years'), Symbol('Meet DSM-IV criteria for BPD as assessed by the Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II)'), Symbol('Must have maximum age of 55 Years'), Symbol('Must have minimum age of 18 Years'), Symbol('Provide written informed consent before beginning any study related activities'), Not(Or(Symbol('Are pregnant or lactating'), Symbol('Are undergoing an acute withdrawal syndrome from drugs or alcohol'), Symbol('Had an unsatisfactory response to a previous adequate trial of quetiapine as judged by a study investigator'), Symbol('Have an Axis I diagnosis of Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder or Bipolar I Disorder as diagnosed by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), and pertinent subsequent for ruling out exclusionary diagnoses'), Symbol('Have an unstable medical disorder as determined by physical examination or laboratory testing. The primary investigator will be responsible for making this judgment based on the above'), Symbol('Have participated in any other studies involving investigational products within 30 days prior to entry into this study'), Symbol('Patients cannot begin psychotherapy during the study period, but may continue if started prior to the study'), Symbol('Patients who are currently receiving quetiapine therapy may not undergo a washout period and then restart quetiapine in the study'))))"
}